Basic Information
Xtandi
0469-1725
Regulatory Information
0469-1725
NDA213674
C73594
November 20, 2023
USA
These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI. XTANDI (enzalutamide) capsules, for oral useXTANDI (enzalutamide) tablets, for oral useInitial U.S. Approval: 2012
HUMAN PRESCRIPTION DRUG LABEL
19
Company Information
605764828
Active Ingredients
Active Moieties
ENZALUTAMIDE
Code: 93T0T9GKNU